Table 2.

ORs and 95% CIs for HPV-16 positive ICC according to HLA.

	Controls (n = 257)	HPV-16 Cases (n = 112)
HLA			Crude	Adjustedd
	C/Na	C/N	ORb	OR	CIc
DQA1
*0102	80/177	39/73	1.18	1.22	0.73–2.04
DQB1
*0501	71/186	25/87	0.75	0.72	0.40–1.27
*06	87/170	46/66	1.36	1.32	0.80–2.17
*0602	44/213	30/82	1.77	1.59	0.89–2.83
DRB1
*01	52/205	22/90	0.96	0.89	0.49–1.64
*0102	29/228	12/100	0.94	0.83	0.38–1.79
*04	74/183	23/89	0.64	0.67	0.38–1.19
*13	61/196	19/93	0.66	0.78	0.42–1.45
*1302	27/230	4/108	0.32	0.43	0.14–1.32
DRB1-DQB1 haplotypes
0102–0501	29/228	12/100	0.94	0.59	0.23–1.51
15-0602	33/224	28/84	2.26	2.12	1.15–3.93
1503-0602	14/243	15/97	2.68	2.77	1.20–6.39
08041-0301	5/252	3/109	1.39	0.88	0.14–5.47
09012-0201/02	3/254	3/109	2.33	3.02	0.56–16.29

a) C/N: Carriers/Non carriers;

b) OR: Odds Ratio;

c) CI: Confidence Interval;

d) Adjusted for age and ethnic group.